Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
8-oxoguanine
12%
Aberrations
22%
Anti-amyloid Treatment
12%
APP/PS1 Mouse Model
12%
Cell Adhesion
12%
Checkpoint Kinase 1 (CHK1)
12%
Chromosome 11q
12%
Combined Targeting
12%
CRISPR-Cas9 Genome Editing
14%
Cyclin-dependent Kinase 4 (CDK4)
25%
D4Z4
43%
D4Z4 Repeat
24%
Derepression
15%
DNA Methyltransferase 3B (DNMT3B)
19%
Drug Screening
27%
DUX4
35%
Dysferlin
12%
Epigenetic Repression
14%
Exon Deletion
18%
Facioscapulohumeral muscular Dystrophy
75%
FSHD2
35%
Fusion Protein
14%
Gene Expression Pattern
12%
Human Monocytes
12%
Hypomethylation
14%
ICF Syndrome
15%
ICF2
12%
Isogenic
13%
Loss Amplification
12%
Loss Function
14%
Murine Double Minute 2 (MDM2)
12%
Muscle Differentiation
12%
Mutation Spectrum
14%
Mutational Spectrum
12%
MUTYH
12%
MYCN Amplification
12%
Neuroblastoma
100%
OGG1
12%
Patient Characteristics
12%
Pediatric
15%
Pediatric Malignancy
14%
Pediatric Tumors
23%
Protein Level
14%
Repair Pathway
12%
SMCHD1
51%
Synergistic Effect
14%
Synergistic Response
14%
Therapeutic Target
25%
Therapeutic Vulnerability
15%
Tumor Characteristics
12%
Medicine and Dentistry
Biogenesis
5%
Biological Marker
13%
Cancer
12%
Cell Line
5%
Cell Mutant
5%
Checkpoint Kinase 1
12%
Childhood Cancer
8%
Chromosome 11q
12%
Clinical Trial
7%
Diseases
7%
DNA Damage Response
12%
DNA Repair
5%
Drug Screening
27%
Drug Sensitivity
17%
Ewing Sarcoma
7%
Ex Vivo
12%
Facioscapulohumeral Muscular Dystrophy
23%
Ganglioglioma
6%
Ganglioneuroblastoma
48%
Genetics
22%
Homologous Recombination
5%
Intracranial Tumor
12%
Irinotecan
12%
Lethality
12%
Medulloblastoma
8%
Microphthalmia
12%
Molecular Profiling
12%
Olaparib
10%
Osteosarcoma
5%
PARP Inhibitor
5%
Pediatric Cancer
7%
Pediatrics
40%
Personalized Medicine
12%
Poly ADP Ribose Polymerase
12%
Precision Oncology
12%
Recombination Repair
5%
Rhabdomyosarcoma
8%
Solid Malignant Neoplasm
23%
Therapeutic Target
27%
Tumor
12%
Xenograft
9%
Biochemistry, Genetics and Molecular Biology
Alpha Thalassemia/Mental Retardation X-Linked
25%
Chromatin
29%
Chromosome
12%
Chromosome 11q
12%
Chromosome 4
15%
Clinical Trial
12%
CRISPR/Cas9
15%
Derepression
20%
DNA Methyltransferase
12%
DNMT3B
12%
DUX4
47%
Epigenetic Repression
14%
Exon
14%
Gender Bias
12%
Gene Expression
12%
Genetics
16%
Genome Editing
14%
Guanine
12%
Hemizygosity
12%
Intron
9%
Kinase
12%
Methylation
14%
Methylation Analysis
6%
Missense
21%
MUTYH
12%
Myogenesis
12%
N-Terminus
6%
Nucleotide
6%
P14arf
5%
P53
12%
Penetrance
25%
Phosphotransferase
12%
Proband
6%
Repressor
7%
Skeletal Muscle
6%
Somatic Cell
6%
Synthetic Lethality
12%
Wild Type
5%
X-Inactivation
6%
